Adolph, Timon E.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 2,897

The intestinal microbiota fuelling metabolic inflammation

Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 1,089

Gut-liver axis: Pathophysiological concepts and clinical implications

Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism

Gut microbiota and healthLiver Disease and Transplantation

Cited by 843

The Intestinal Microbiota in Colorectal Cancer.

Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell

Gut microbiota and healthColorectal Cancer Treatments and Studies

Cited by 777

Paneth cells as a site of origin for intestinal inflammation

Adolph, T. E., Tomczak, M. F., Niederreiter, L., Ko, H.-J., Böck, J., Martinez-Naves, E., Glickman, J. N., Tschurtschenthaler, M., Hartwig, J., Hosomi, S., et al. (2013) · Nature

Inflammatory Bowel DiseaseAutophagy in Disease and Therapy

Cited by 732

Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease

Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut

Gut microbiota and healthAlcohol Consumption and Health Effects

Cited by 618

Calprotectin: from biomarker to biological function

Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut

Inflammatory Bowel DiseaseS100 Proteins and Annexins

Cited by 500

Lipocalin 2 protects from inflammation and Tumorigenesis associated with gut microbiota alterations

Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., Hackl, H., Pfister, A., Schilling, J., Moser, P. L., et al. (2016) · Cell Host & Microbe

Gut microbiota and healthInflammatory Bowel Disease

Cited by 375

Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation

Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V., & Tilg, H. (2017) · Trends in Endocrinology & Metabolism

Adipokines, Inflammation, and Metabolic DiseasesInflammation biomarkers and pathways

Cited by 359

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease

Mayr, L., Grabherr, F., Schwärzler, J., Reitmeier, I., Sommer, F., Gehmacher, T., Niederreiter, L., He, G.-W., Ruder, B., Kunz, K. T. R., et al. (2020) · Nature Communications

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 292

NAD metabolism fuels human and mouse intestinal inflammation

Gerner, R. R., Klepsch, V., Macheiner, S., Arnhard, K., Adolph, T. E., Grander, C., Wieser, V., Pfister, A., Moser, P., Hermann-Kleiter, N., et al. (2018) · Gut

Sirtuins and Resveratrol in MedicineInflammatory Bowel Disease

Cited by 192

The microbiota: An underestimated actor in radiation-induced lesions?

Sokol, H., & Adolph, T. E. (2018) · Gut

Effects of Radiation ExposureGut microbiota and health

Cited by 52

A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?

Tilg, H., Effenberger, M., & Adolph, T. E. (2020) · Expert Opinion on Investigational Drugs

Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic Diseases

Cited by 28